Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.36 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19079946 | 0.90 | PLA2G2A (0.40) | PLA2G2APLA2G4APLA2G10PRKDCHSD17B1 | |
| SCHEMBL19079982 | 0.88 | CA12 (0.36) | PLA2G2APLA2G4APLA2G10PRKDC | |
| SCHEMBL19080032 | 0.88 | CDK1 (0.33) | PLA2G2APLA2G4APLA2G10GPR84 | |
| SCHEMBL19080126 | 0.87 | CA12 (0.40) | PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL24652280 | 0.83 | CA12 (0.34) | PRKDC | |
| SCHEMBL17931916 | 0.83 | CDC14B (0.40) | PLA2G2APLA2G4APLA2G10GPR84 | |
| SCHEMBL19080133 | 0.83 | CYP1A1 (0.43) | PRKDC | |
| SCHEMBL19080014 | 0.83 | CYP1A1 (0.40) | PLA2G2APLA2G4APLA2G10GPR84PRKDC | |
| SCHEMBL17931914 | 0.83 | CDC14B (0.36) | PLA2G2APLA2G4APLA2G10GPR84 | |
| SCHEMBL17944429 | 0.83 | CDC14B (0.36) | GPR84PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10580999-B2 | Condensed cyclic compound and an organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20170194571-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
| US-20170194571-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194571-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNA1 | PLA2G2A 4537/4885PLA2G4A 4462/4885PLA2G10 4289/4885 |
| US-10580999-B2 | Condensed cyclic compound and an organic light-emitting device including the same | CRY1, CRY2, CCNA1 | PLA2G2A 4537/4885PLA2G4A 4462/4885PLA2G10 4289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.